Hobson Leavy is delighted to announce that Scott Sherriff has been appointed Chief Operating Officer for Aroa Biosurgery.
Scott Sherriff is a senior executive with over twenty-five years’ experience in the pharmaceutical industry, much of which has been internationally focused and offshore based. He offers strong skills in leadership roles across sales and marketing and managing large cross-functional global teams.
Since 2015 Scott has been employed as Chief Commercial Officer with Douglas Pharmaceuticals in New Zealand, joining the company on returning here after nearly twenty years offshore.
He offers extensive experience providing strategic and operational leadership to global teams, having launched, and marketed new products into global markets in as many as forty countries at a time. He is highly adept at understanding his consumers, differing markets, and navigating the complexities involved.
Please join us in congratulating Scott on his appointment
